Jan Bewersdorf
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Jan Bewersdorf
Jun 18, 2024, 23:17 |
Insight
Talha Badar: TP53 mutation in Myeloproliferative neoplasms
Talha Badar shared on X: , "Genomic landscape, impact allelic burden, time to…
Jun 17, 2024, 04:18 |
Blog
Amer Zeidan: Amazing work by our fellows, 6 posters at EHA2024
Amer Zeidan shared on X/Twitter: "Amazing work by our fellows at Yale Hematology Oncology Fellows presenting…
Dec 15, 2023, 06:18 |
Blog
Amer Zeidan: A proud moment as a mentor
Amer Zeidan shared a post on his X/Twitter page: "A proud moment as a mentor…
Oct 10, 2023, 21:35 |
Opinion
Justin Taylor: We show that E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies.
Justin Taylor, Assistant Professor at UM Sylvester Comprehensive Cancer Center and Principle Investigator at the…
Sep 25, 2023, 16:57 |
Insight
Lucia Masarova: Disease modification time in Polycythemia Vera is here!
Lucia Masarova, oncology specialist in Houston, TX, shared a post by Naveen Pemmaraju, on Twitter: "Disease…
All:
5
Posts:
1 - 10
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube